Association of Toll-like Receptor 4 (TLR4) Gene Polymorphism with Multiple Sclerosis (MS) in Iranian Patients

Author:

Jahromi Abdolreza Sotoodeh12,Erfanian Saiedeh34,Jahromi Mohammad Sobhan Safavi1,Roustazadeh Abazar34

Affiliation:

1. Research Center for Noncommunicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran

2. Immunology Department, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran

3. Department of Biochemistry, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran

4. Department of Advanced Medical Sciences and Technologies, Faculty of Medicine, Jahrom University of Medical Sciences, Jahrom, Iran

Abstract

Objective: Multiple sclerosis (MS) is a chronic debilitating disease with unknown pathogenesis. Recent studies indicated that pathogen recognition receptors such as toll-like receptor 4 (TLR4) may have a role in the pathogenesis of MS. The aim of the study was to evaluate the association of rs1927911 polymorphism in the TLR4 gene with MS. Methods: Four hundred subjects, including 200 MS patients and 200 healthy individuals, were recruited for the study. Patients were included secondary-progressive, primary-progressive, and relapsing-remitting subtypes. Polymerase chain reaction-restriction fragment length polymorphism was performed to identify rs1927911 genotypes in the TLR4 gene. Results: The mean age of the healthy and MS groups was 34.22 ± 1.3 and 33.2 ± 0.98, respectively. The frequency of TT, TC, and CC was 29/52, 132/128, and 39/20, respectively, in MS compared to healthy controls. Genotype and allele distributions were significantly different between both the groups (P < 0.05). In addition, TC (odds ratio [OR] = 1.849, 95% confidence interval [CI] = 1.105–3.095, P = 0.019) and CC (OR = 3.497, 95% CI = 1.728–7.076, P = 0.001) genotypes had increased the risk of MS. Conclusion: Our findings showed a significant relationship between rs1927911 polymorphism in the TLR4 gene and MS. We concluded that rs1927911 genotype variations may increase the risk of MS. Further studies in other populations are recommended to support our findings.

Publisher

Medknow

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3